OR2T29

Across TCGA pan-cancer cohorts, OR2T29 RNA is linked to patient survival in 5 of 34 cancer types, making it the most broadly survival-associated OR2T29 data layer compared with 1 for mutation status.

The strongest signal is observed in thyroid carcinoma (THCA), where higher OR2T29 RNA is associated with worse overall survival. In most high-consensus cancer types, elevated OR2T29 expression acts as an unfavorable survival marker.

THCA, COAD, and SKCM are the cancer types where OR2T29 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
THCA	OS	Tertile	All	0.928	0.990	<.001	81	view →
COAD	OS	Tertile	All	0.196	0.806	.005	45	view →
SKCM	DFS	Tertile	All	0.054	0.728	<.001	45	view →
UCEC	OS	Tertile	III,IV	0.053	0.588	.005	42	view →
SARC	OS	Tertile	All	0.016	0.861	<.001	36	view →

Pink = unfavorable, green = favorable. Showing the 5 strongest of 5 lineages.

OR2T29–THCA (OS)

Open the THCA breakdown →